William Schuyler Jones, MD

Associate Professor of Medicine
Associate Professor in Population Health Sciences
Member of the Duke Clinical Research Institute
Campus mail 2400 Pratt Street, 7037, Durham, NC 27705
Phone (919) 668-8917
Email address schuyler.jones@duke.edu

I am an interventional cardiologist with a specific focus on the diagnosis and treatment of patients with cardiovascular disease. As a clinician, I see patients in the office and do coronary and peripheral vascular procedures (angiography and interventions) in the Duke Cardiac Catheterization Laboratory. I have served as the Medical Director of the cath lab at Duke since 2016. Alongside my partners in the cath lab, we collaborate with our cardiothoracic surgeons to hold Heart Team meetings each week, and we frequently are asked to address complex cardiovascular issues as a multidisciplinary team.

I also have a broad background in cardiovascular site-based research, multicenter clinical trials, clinical event classification, and observational analyses. I have helped to lead clinical trial efforts at the Duke Clinical Research Institute (DCRI) by designing and conducting studies evaluating new and existing treatments for patients with coronary artery disease and peripheral artery disease. My specific research interests include examining access to care and disparities in care for patients with peripheral artery disease and the design and conduct of pragmatic clinical trials in cardiovascular disease.

In Their Words

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 2004 - 2005
  • Medical Resident, Medicine, Duke University, 2001 - 2004
  • M.D., University of Arkansas, Little Rock, 2001

Publications

Jones, W Schuyler, Lisa M. Wruck, Robert A. Harrington, and Adrian F. Hernandez. “Iterative approaches to the use of electronic health records data for large pragmatic studies.” Contemp Clin Trials 117 (May 8, 2022): 106789. https://doi.org/10.1016/j.cct.2022.106789.

PMID
35545204
Full Text

Piccini, Jonathan P., Valeria Caso, Stuart J. Connolly, Keith A. A. Fox, Jonas Oldgren, W Schuyler Jones, Diana A. Gorog, et al. “Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.” Lancet 399, no. 10333 (April 9, 2022): 1383–90. https://doi.org/10.1016/S0140-6736(22)00456-1.

PMID
35385695
Full Text

Pohlman, F Will, Cassie B. Ford, E Hope Weissler, Michelle M. Smerek, N Chantelle Hardy, Dennis I. Narcisse, Steven J. Lippmann, et al. “Impact of risk factor control on peripheral artery disease outcomes and health disparities.” Vasc Med, April 7, 2022, 1358863X221084360. https://doi.org/10.1177/1358863X221084360.

PMID
35387516
Full Text

Huang, Zhen, Frank W. Rockhold, W Schuyler Jones, Adrian F. Hernandez, Debbe McCall, David L. DeMets, Judith S. Hochman, et al. “The challenges of data safety monitoring for a pragmatic study: Lessons from the ADAPTABLE study.” Contemp Clin Trials 115 (April 2022): 106732. https://doi.org/10.1016/j.cct.2022.106732.

PMID
35301133
Full Text

Norgren, Lars, Rebecca North, Iris Baumgartner, Jeffrey S. Berger, Juuso I. Blomster, William R. Hiatt, W Schuyler Jones, et al. “World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial.” Vasc Med 27, no. 1 (February 2022): 21–29. https://doi.org/10.1177/1358863X211038620.

PMID
34516308
Full Text

Weissler, E Hope, Cassie B. Ford, Dennis I. Narcisse, Steven J. Lippmann, Michelle M. Smerek, Melissa A. Greiner, N Chantelle Hardy, et al. “Clinician Specialty, Access to Care, and Outcomes Among Patients with Peripheral Artery Disease.” Am J Med 135, no. 2 (February 2022): 219–27. https://doi.org/10.1016/j.amjmed.2021.08.025.

PMID
34627781
Full Text

Govsyeyev, Nicholas, Mark R. Nehler, Cecilia C. Low Wang, Sarah Kavanagh, William R. Hiatt, Chandler Long, W Schuyler Jones, et al. “Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trial.” J Vasc Surg 75, no. 2 (February 2022): 660-670.e3. https://doi.org/10.1016/j.jvs.2021.08.096.

PMID
34597783
Full Text

Salisbury, Adam C., David M. Safley, Kevin F. Kennedy, Bhaskar Bhardwaj, Herbert D. Aronow, William Schuyler Jones, Dmitriy N. Feldman, et al. “Development and validation of a predictive model for bleeding after peripheral vascular intervention: A report from the National Cardiovascular Data Registry Peripheral Vascular Interventions Registry.” Catheter Cardiovasc Interv 98, no. 7 (December 1, 2021): 1363–72. https://doi.org/10.1002/ccd.29961.

PMID
34569709
Full Text

Hsia, Judith, Sarah T. Kavanagh, Charles W. Hopley, Iris Baumgartner, Jeffrey S. Berger, Gerry R. Fowkes, W Schuyler Jones, et al. “Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y12 inhibitors: Insights from the EUCLID trial.” Vasc Med 26, no. 6 (December 2021): 608–12. https://doi.org/10.1177/1358863X211017641.

PMID
34082620
Full Text

Pages